Cx601 (expanded allogenic adipose-derived stem cells)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Cx601 (expanded allogenic adipose-derived stem cells), covering 2019-04-12 to 2019-04-12. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess the Safety and Efficacy of Expanded Allogenic Adipose-derived Stem Cells (eASCs) (Cx601), for Treatment of Complex Perianal Fistulas in Perianal Crohn's Disease. [Phase 1, Phase 2]